Acta Scientific Clinical Case Reports

Perspective Volume 2 Issue 11

Stem Cell Therapy for Chronic Renal Failure

Lowell L Lewis*

Director, Montserrat Institute of Surgical Research and Education, Brades, Montserrat, West Indies

*Corresponding Author: Lowell L Lewis, Director, Montserrat Institute of Surgical Research and Education, Brades, Montserrat, West Indies.

Received: August 25, 2021; Published: 6 October, 2021

×

Question

PCI– Percutaneous Renal Stem cell infiltration therapy.

Easier than renal transplantation.

Review Papers: Elsevier Biomaterials 2014.

Promotion of Cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction

Wang., et al. Tissue engineering Research Centre Academy of Military Medial Sciences Beijing China.

×

References

×

Citation

Citation: Lowell L Lewis. “Stem Cell Therapy for Chronic Renal Failure". Acta Scientific Clinical Case Reports 2.11 (2021): 19-23.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.278

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 25, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US